{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Broomfield",
      "address_1": "2555 W Midway Blvd",
      "reason_for_recall": "Impurities/Degradation Products: An out of specification result for a known impurity of the product occurred during 12 month stability testing.",
      "address_2": "",
      "product_quantity": "43,060 x 90 count bottles",
      "code_info": "Lot numbers: BJ3338; BJ3339; BJ 3340; BJ3341; BJ3342; BJ6282; BJ7192; BM8498; BJ7202; BJ7203, Exp 12/12",
      "center_classification_date": "20120919",
      "distribution_pattern": "Nationwide",
      "state": "CO",
      "product_description": "Pramipexole Dihydrochloride Tablets, 0.25 mg, 90-count tablets per bottle, Rx only, Manufactured in India by Sandoz Private Ltd., for Sandoz Inc., Princeton, NJ 08540, NDC 0781-  5249-92,",
      "report_date": "20120926",
      "classification": "Class III",
      "openfda": {},
      "recalling_firm": "Sandoz Incorporated",
      "recall_number": "D-1677-2012",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "63160",
      "termination_date": "20130410",
      "more_code_info": "",
      "recall_initiation_date": "20120912",
      "postal_code": "80020-1632",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}